Premium
Predictors of the placebo response in functional dyspepsia
Author(s) -
TALLEY N. J.,
LOCKE G. R.,
LAHR B. D.,
ZINSMEISTER A. R.,
COHARDRADICE M.,
D'ELIA T. V.,
TACK J.,
EARNEST D. L.
Publication year - 2006
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/j.1365-2036.2006.02845.x
Subject(s) - placebo , medicine , gastric emptying , placebo response , body mass index , clinical trial , quality of life (healthcare) , gastroenterology , stomach , pathology , alternative medicine , nursing
Summary Background Trials in functional dyspepsia report placebo response rates of 30% to 40%. Aim We aimed to identify predictors of the placebo response. Methods Patients from primary, secondary and tertiary practices with functional dyspepsia defined by Rome II criteria were enrolled into one of four clinical trials; 220 patients were randomized to receive placebo. Scintigraphic assessment of gastric emptying at baseline was repeated at the end of the treatment in those with delayed emptying. After a 2 week run‐in period, patients were followed for 8 weeks on placebo. Response was assessed on a weekly basis and a responder was defined as satisfactory relief of meal‐related symptoms on at least 50% of weeks. Results The mean age was 44 years (range 18–82) and 74% were female; 76 (35%) were placebo responders. The predominant symptom was an unstable measure over the trial. Independent predictors of a lower placebo response were lower body mass index and a more consistent predominant symptom pattern (both P < 0.05). No association was seen with age, gender, centre type, baseline symptom score, baseline or change in gastric emptying, or baseline quality of life. Conclusion In functional dyspepsia, a consistent predominant symptom pattern and lower body mass index may be associated with a lower placebo response rate.